Overview

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) and offers a range of innovative products, including the iStent platform and the iDose TR implant.

Therapeutic areas

GlaucomaCorneal DisordersRetinal Diseases

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832025-04-22

    Investigations of discrepancies, failures

Verified Supplier Partner

Is this Glaukos Corporation? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.